IL-8 was shown to stimulate the release of inflammatory mediators, promoting HNSCC cell migration and increasing the expression of matrix metalloproteinases 2 and 9, known stimulating factors of the epithelial–mesenchymal transition [45,46]. The gene discussed is CXCL8; the disease is head and neck squamous cell carcinoma.